Bihua Chen
director
immunology
Anda Pharmaceuticals Inc
Aruba
Biography
Bihua Chen is CEO and Portfolio Manager at Cormorant Asset Management. Ms. Chen founded Cormorant Asset Management LLC (“Cormorant”) in 2013 and currently manages investments in public and private biopharmaceutical companies totaling over $800m. Prior to founding Cormorant, Ms. Chen managed a separately managed account focused on the healthcare sector as a sub-adviser to a large, multi-strategy hedge fund based in New York. Ms. Chen obtained an MBA from the Wharton School of Business in 1998 and graduated with a Master of Science, Molecular Biology, from the Graduate School of Biomedical Science at Cornell Medical College in 1994. Ms. Chen also holds a Bachelor of Science degree in Genetics and Genetic Engineering from Fudan University, Shanghai, China, which she received in 1990.
Research Interest
Bihua Chen is CEO and Portfolio Manager at Cormorant Asset Management. Ms. Chen founded Cormorant Asset Management LLC (“Cormorant”) in 2013 and currently manages investments in public and private biopharmaceutical companies totaling over $800m. Prior to founding Cormorant, Ms. Chen managed a separately managed account focused on the healthcare sector as a sub-adviser to a large, multi-strategy hedge fund based in New York. Ms. Chen obtained an MBA from the Wharton School of Business in 1998 and graduated with a Master of Science, Molecular Biology, from the Graduate School of Biomedical Science at Cornell Medical College in 1994. Ms. Chen also holds a Bachelor of Science degree in Genetics and Genetic Engineering from Fudan University, Shanghai, China, which she received in 1990.
